Trump administration expected to make an announcement on autism

The Trump administration is expected to make an announcement on autism today, according to multiple reports.

Officials on the condition of anonymity told The Washington Post and Politico that the administration is expected to speak about autism and how the active ingredient in Tylenol, acetaminophen, may be tied to an increased autism risk in children if taken in early pregnancy. The maker of Tylenol, Kenvue, has denied the link between autism and its drug. It said that it believes that taking acetaminophen does not cause autism, Reuters reported.

The administration will also be offering up what it believes is a drug that can treat autism, officials said, according to Politico.

White House Press Secretary Karoline Leavitt is set to give a briefing on U.S. President Donald Trump’s agenda at 1 p.m. ET. Trump is expected to speak about autism research at 4 p.m. ET from the Roosevelt Room of the White House.

• Is the 'autism epidemic' real? Researchers say over-diagnosis to blame for spike in number of cases
• Autistic teen who came to Canada arrested in Japan after meth found in suitcase, family says

Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark nationalpost.com and sign up for our daily newsletter, Posted, here.